Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

BD BACTEC™ Plus Aerobic/F Culture Vials

K-Number: K222591 · 2023-03-24

Decision Date2023-03-24
Product CodeMDB
Advisory CommitteeMI
DecisionSubstantially Equivalent

Device Summary

BD BACTEC™ Plus Aerobic/F Culture Vials is a medical device manufactured by Becton, Dickinson and Company. It received FDA 510(k) clearance on 2023-03-24 under approval number K222591. The device is classified under product code MDB. It was reviewed by the MI advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the BD BACTEC™ Plus Aerobic/F Culture Vials?

BD BACTEC™ Plus Aerobic/F Culture Vials is a medical device that received FDA 510(k) clearance on 2023-03-24. It is manufactured by Becton, Dickinson and Company. The 510(k) number is K222591.

When was BD BACTEC™ Plus Aerobic/F Culture Vials approved by the FDA?

BD BACTEC™ Plus Aerobic/F Culture Vials received FDA 510(k) clearance on 2023-03-24, under approval number K222591.

What company makes BD BACTEC™ Plus Aerobic/F Culture Vials?

BD BACTEC™ Plus Aerobic/F Culture Vials is manufactured by Becton, Dickinson and Company.

What is the FDA product code for BD BACTEC™ Plus Aerobic/F Culture Vials?

The FDA product code for BD BACTEC™ Plus Aerobic/F Culture Vials is MDB.

Other Devices by Becton, Dickinson and Company

View all 100 devices →

Related Devices (Code: MDB)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.